Amyotrophic Lateral Sclerosis

(ALS; Lou Gehrig's Disease; Motor Neuron Disease)
  • Definition

    Amyotrophic lateral sclerosis (ALS) is a progressive nervous system disorder. It gradually destroys the nerves responsible for muscle movement. Over time, ALS leads to almost total paralysis of muscle movement, including breathing. Eventually, the disorder leads to respiratory failure.
    The Nervous System
    Nucleus factsheet image
    Copyright © Nucleus Medical Media, Inc.
  • Causes

    The cause of ALS is unknown. Genes may play a role.
  • Risk Factors

    Factors that may increase your risk of getting ALS include:
    • Having a family member with ALS
    • Being in the military or having other occupations with risk of exposure
    • Having certain genetic mutations
  • Symptoms

    Symptoms of ALS include:
    • Progressive weakness in arms and legs
    • Wrist or foot drop
    • Difficulty holding things
    • Frequent tripping while walking
    • Muscle twitching
    • Unpredictable and changing emotions
    • Slurred speech
    • Hoarseness and coughing
    • Trouble chewing and swallowing, resulting in frequent choking and gagging
    • Weight loss due to trouble eating
    • Trouble breathing
    • Excess salivation, drooling
  • Diagnosis

    You will be asked about your symptoms and medical history. A physical exam will be done. There are no tests that can diagnose ALS. Tests may be used to rule out other medical conditions.
    Images may be taken of your bodily structures. This can be done with:
    Your bodily fluids and tissues may be tested. This can be done with:
    • Blood tests
    • Lumbar puncture
    • Biopsy
    Your muscles and nerves may be evaluated. This can be done with electromyogram (EMG)/nerve conduction velocities (NCV).
    Your cognitive skills may be assessed. This can be done with neuropsychological testing.
  • Treatment

    There is currently no cure for ALS.
    Treatment may help to reduce or manage symptoms. A combination of treatments may work best. This may include:
    • Taking medications
    • Working with therapists and joining a support group
    • Participating in social activities
    Treatment options include:
    Medications
    The drug riluzole has been approved for ALS. The drug may slightly improve functioning, but it does not stop the disease from progressing.
    You may be prescribed these medicines for symptoms:
    • Muscle relaxants reduce spasticity
    • Nonsteroidal anti-inflammatory drugs (NSAIDs) and other pain medications
    • Atropine, scopolamine, botulinum toxin, antihistamine—To reduce heavy drooling
    • Antidepressants and anti-anxiety medications
    • A combination of dextromethorphan and quinidine—To treat inappropriate laughter or crying
    Other Types of Treatments
    Supportive care may be needed as ALS progresses, including:
    • Physical therapy—To reduce pain associated with muscle cramping and spasticity
    • Respiratory care—In some cases, you may need to receive a mixture of air and oxygen from a machine. A device may also be used that helps your breathing muscles contract. If you cannot move enough air in and out of your lungs, you may need surgery to have a tube inserted into your airway.
    • Nutritional care—Your doctor may make changes to your diet. In some cases, getting nutrition through tube feeding is needed.
    • Speech therapy—Speech therapy may be used to optimize communication. Therapy may include exploring alternate methods of communication.
  • Prevention

    There are no guidelines for preventing ALS because the cause is unknown.
  • RESOURCES

    ALS Association http://www.alsa.org

    National Institute of Neurological Disorders and Stroke http://www.ninds.nih.gov

    CANADIAN RESOURCES

    ALS Society of British Columbia http://www.alsbc.ca

    ALS Society of Canada http://www.als.ca

    References

    Aggarwal, SP, Zinman L, Simpson E, et al. Clinical trial testing lithium in ALS terminates early for futility. Lancet Neurol. 2010; 9(5): 481-488.

    Amyotrophic lateral sclerosis. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed. Updated February 4, 2014. Accessed February 12, 2014.

    Amyotrophic lateral sclerosis fact sheet. National Institute of Neurological Disorders and Stroke website. Available at: http://www.ninds.nih.gov/disorders/amyotrophiclateralsclerosis/detail%5Famyotrophiclateralsclerosis.htm. Updated February 5, 2014. Accessed February 12, 2014.

    FDA approves NeuRx Diaphragm Pacing System. ALS Association website. Available at: http://www.alsa.org/news/archive/fda-approves-neurx-diaphragm.html. Updated September 29, 2011. Accessed February 12, 2014.

    NeuRx Diaphragm Pacing System. US Food & Drug Administration website. Available at: http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/Recently-ApprovedDevices/ucm278684.htm. Updated September 6, 2013. Accessed February 12, 2014.

    Sathasivam S. Managing patients with amyotrophic lateral sclerosis. Eur J Intern Med. 2009;24:355-358.

    Walling AD. Amyotrophic lateral sclerosis: Lou Gehrig's disease. Am Fam Physician. 1999;59:1489-1496.

    4/17/2008 DynaMed Systematic Literature Surveillance http://www.ebscohost.com/dynamed: Fornai F, Longone P, Cafaro L, et al. Lithium delays progression of amyotrophic lateral sclerosis. Proc Natl Acad Sci USA . 2008;105:2052-2057.

    1/14/2011 DynaMed's Systematic Literature Surveillance http://www.ebscohost.com/dynamed: Mateen FJ, Carone M, Sorenson EJ. Patients who survive 5 years or more with ALS in Olmsted County, 1925-2004. J Neurol Neurosurg Psychiatry. 2010;81(10):1144-1146.

    Revision Information

  • Connect with Steward

    Visit Our Twitter Feed Visit Our Facebook Page Email This Page Print This Page

    Subscribe to our patient e-newsletter

    Copyright © 2014 Steward Health Care
    Connect Healthcare Panacea CMS Solutions